Skip to main content
SpringerLink
Log in

Ernstige hypoglycemieën en cardiovasculaire complicaties: consequenties voor de behandeling?

  • Commentaar
  • Published:
Nederlands Tijdschrift voor Diabetologie Aims and scope

Samenvatting

Patiënten met type 1 en type 2 diabetes die met insuline of sulfonylureumderivaten worden behandeld hebben een verhoogd risico op hypoglycemieën. Weliswaar is dat risico bij patiënten met type 1 diabetes het grootst, maar ook patiënten met type 2 diabetes kunnen er mee te maken krijgen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenties

  1. Kooy A: Hypoglycemie bij diabetes: relevant voor het cardiovasculair risico en de cognitie? Nederlands Tijdschrift voor Diabetologie 2011;52–61

  2. Gerstein HC, Miller ME, Byington RP, Goff DC, Jr., Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Jr., Probstfield JL, Simons-Morton DG, Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559

    Article  CAS  PubMed  Google Scholar 

  3. Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, Dudl RJ, Ismail-Beigi F, Kimel AR, Hoogwerf B, Horowitz KR, Savage PJ, Seaquist ER, Simmons DL, Sivitz WI, Speril-Hillen JM, Sweeney ME: The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010;340:b4909

    Article  PubMed Central  PubMed  Google Scholar 

  4. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S: Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010;363:1410–1418

    Article  CAS  PubMed  Google Scholar 

  5. Libby P, Maroko PR, Braunwald E: The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion. Circulation 1975;51:621–626

    Article  CAS  PubMed  Google Scholar 

  6. Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V: Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 2003;26:1485–1489

    Article  PubMed  Google Scholar 

  7. Gill GV, Woodward A, Casson IF, Weston PJ: Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes-the ‘dead in bed’ syndrome revisited. Diabetologia 2009;52:42–45

    Article  CAS  PubMed  Google Scholar 

  8. Campbell I: Dead in Bed Syndrome - A New Manifestation of Nocturnal Hypoglycemia. Diabetic Medicine 1991;8:3–4

    Article  CAS  PubMed  Google Scholar 

  9. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643–2653

    Article  PubMed  Google Scholar 

  10. Ferguson SC, Blane A, Perros P, McCrimmon RJ, Best JJ, Wardlaw J, Deary IJ, Frier BM: Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 2003;52:149–156

    Article  CAS  PubMed  Google Scholar 

  11. Austin EJ, Deary IJ: Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care 1999;22:1273–1277

    Article  CAS  PubMed  Google Scholar 

  12. de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M, Hamet P, Heller SR, Lisheng L, MacMahon S, Mancia G, Neal B, Pan CY, Patel A, Poulter N, Travert F, Woodward M: Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009;52:2328–2336

    Article  PubMed  Google Scholar 

  13. Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK: Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 2009;361:1736–1747

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Afdeling Algemeen Interne Geneeskunde, UMC St Radboud, 9101, 6500, Nijmegen, HB, The Netherlands

    Bastiaan de Galan

Authors
  1. Bastiaan de Galan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bastiaan de Galan.

Additional information

1 Afdeling Algemeen Interne Geneeskunde, UMC St Radboud, Nijmegen

Correspondentie:

Afdeling Algemeen Interne Geneeskunde 463, UMC St Radboud, Postbus 9101, 6500 HB Nijmegen

B.deGalan@aig.umcn.nl

Conflict of interest:

Geen gemeld.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Galan, B. Ernstige hypoglycemieën en cardiovasculaire complicaties: consequenties voor de behandeling?. NED. TIJDSCHR. DIABET. 9, 43–45 (2011). https://doi.org/10.1007/s12467-011-0014-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12467-011-0014-7

Search

Navigation